JOURNAL of
ONCOLOGICAL
SCIENCES

Year 2022 - Volume 8 - Issue 2
Original research article ::.

  • Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study aDepartment of Medical Oncology, University of Health Sciences Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Türkiye bDepartment of Medical Oncology, İstanbul Medeniyet University Göztepe Education and Research Hospital, İstanbul, Türkiye cDepartment of Medical Oncology, İstinye University Hospital Liv Hospital Bahçeşehir, İstanbul, Türkiye DOI: 10.37047/jos.2021-87391 Pages: 63 - 68 376 Viewed.

  • The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer aClinic of Medical Oncology, Ankara City Hospital, Ankara, Türkiye bDivision of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye cDivision of Medical Oncology, Medipol University Faculty of Medicine, İstanbul, Türkiye dDivision of Medical Oncology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Health Application and Research Center, Ankara, Türkiye eDivision of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye fDivision of Medical Oncology, Başkent University Faculty of Medicine, Adana, Türkiye gDivision of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Türkiye DOI: 10.37047/jos.2022-88853 Pages: 69 - 75 326 Viewed.


  • The Impact of Hybrid Capture-Based Comprehensive Genomic Profiling on Treatment Strategies in Patients with Solid Tumors aClinic of Medical Oncology, Acıbadem Adana Hospital, Adana, Türkiye bDivision of Medical Oncology, Başkent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Türkiye cDivision of Medical Oncology, İstanbul Medipol University Faculty of Medicine, İstanbul, Türkiye dDivision of Medical Oncology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye eDivision of Medical Oncology, Demiroğlu Bilim University İstanbul Florence Nightingale Hospital, İstanbul, Türkiye fDivision of Medical Oncology, Bezmiâlem Vakıf University Faculty of Medicine, İstanbul, Türkiye gDivision of Medical Oncology, Hacettepe University Institute of Cancer, Ankara, Türkiye hClinic of Medical Oncology, Medicana International Ankara Hospital, Ankara, Türkiye iClinic of Medical Oncology, American Hospital, İstanbul, Türkiye kClinic of Oncology, Acıbadem Maslak Hospital, İstanbul, Türkiye kClinic of Medical Oncology, Medical Park İzmir Hospital, İzmir, Türkiye lClinic of Medical Oncology, Medicana International İstanbul Hospital, İstanbul, Türkiye mClinic of Oncology, VM Medical Park Pendik Hospital, İstanbul, Türkiye nClinic of Medical Oncology, İstanbul Oncology Hospital, İstanbul, Türkiye oClinic of Medical Oncology, Acıbadem Maslak Hospital, İstanbul, Türkiye Division of Medical Oncology, Koç University Faculty of Medicine, İstanbul, Türkiye rRoche Pharma, İstanbul, Türkiye DOI: 10.37047/jos.2022-89310 Pages: 87 - 93 258 Viewed.


  • Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell Carcinoma aClinic of Medical Oncology, Batman Training and Research Hospital, Batman, Türkiye bDepartment of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Türkiye cDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakır, Türkiye dClinic of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Türkiye eClinic of Medical Oncology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Türkiye fDepartment of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Türkiye DOI: 10.37047/jos.2022-90679 Pages: 100 - 106 317 Viewed.

Review article ::.